In a study on people with obesity and asthma, researchers saw “significant” improvements in the asthma scores of people who ...

CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor Novo Nordisk, will still be covered under plans managed by CVS Caremark.

Weight-loss drugs like semaglutide and tirzepatide may help shrink waistlines, but new research shows they fail to boost ...

A new study reports that mice shed about 20% of their body weight and saw their breast cancer tumors decrease after getting ...

The appetite-suppressing medications reduce consumption of processed and sugary foods, creating new risks and opportunities.

RELATED: Doctors Warn That Drugs Like Ozempic Are Making You “Skinny Fat.” Any time a person suddenly loses weight, they are ...

Weight loss drugs have become quite popular in the past years. However, there are a few aspects of the drug that need to be ...

Beyond Ozempic: New GLP-1 drugs promise weight loss and health benefits Researchers at the American Diabetes Association conference in Orlando are expected to present data on 27 GLP-1 drugs in ...

The popular weight-loss and diabetes drugs could play a significant role not only in disease prevention, but possibly in ...

Unless you are from another planet, you’ve heard all about the new weight loss medications taking the world by storm. These weight loss injections, GLP-1s like Wegovy, (same drug as Ozempic ...

Study finds the GLP-1 drug liraglutide reduced migraine days by almost 50% in patients with obesity, with quality of life improvements occurring despite minimal weight changes.

Beyond Ozempic: New GLP-1 drugs promise weight loss and health benefits Researchers at the American Diabetes Association conference in Orlando are expected to present data on 27 GLP-1 drugs in ...